These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 261572)

  • 21. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
    Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
    Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sensitivity to mezlocillin Gram-negative aerobic bacilli according to their pattern of resistance to the usual beta-lactam antibiotics (author's transl)].
    Witchitz JL; Faurisson F; Christol D
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):314-7. PubMed ID: 6460966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical results with mezlocillin (author's transl)].
    Tettenborn D; Schacht P; Hullmann R; Bruck H
    Arzneimittelforschung; 1979; 29(12a):2009-14. PubMed ID: 543914
    [No Abstract]   [Full Text] [Related]  

  • 25. [Curative action of mezlocillin on experimental infections in mice (author's transl)].
    Crémieux A; Dumenil G; Chevalier J; Bonnaveiro N
    Nouv Presse Med; 1982 Feb; 11(5 Pt 2):332-4. PubMed ID: 6460971
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibiotic therapy in biliary tract infections: clinical experiences with mezlocillin.
    Cristiano P; Iovene MR; Cioffi R; Salerno RA; Sicolo A; Cristinzio G; Paradisi F
    Chemioterapia; 1984 Jun; 3(3):178-82. PubMed ID: 6529774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Degradation of Azlocillin and Mezlocillin / I. Behaviour in biological material and buffer (author's transl)].
    Gundert-Remy U; Weber E
    Arzneimittelforschung; 1981; 31(12):2041-4. PubMed ID: 6460506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacterial incidence and antibiotic sensitivity pattern in moderate and severe infections in hospitalised patients.
    Ghosh A; Karmakar PS; Pal J; Chakraborty N; Debnath NB; Mukherjee JD
    J Indian Med Assoc; 2009 Jan; 107(1):21-2, 24-5. PubMed ID: 19588683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapy with an antibiotic combination mezlocillin/oxacillin and clinical experience/First communication: Adults (author's transl)].
    Chyský V; Hullmann R
    Arzneimittelforschung; 1979; 29(12a):2021-7. PubMed ID: 396931
    [No Abstract]   [Full Text] [Related]  

  • 30. Treatment of severe infections in patients with cancer. The role of new acyl-penicillins.
    Klastersky J
    Arch Intern Med; 1982 Oct; 142(11):1984-7. PubMed ID: 6215007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies on the synergism of sulbactam and beta-lactam antibiotics under in vitro conditions and in healthy volunteers after intravenous administration. Antibacterial activity in vitro, compatibility and pharmacokinetics of the drugs in combination.
    Wildfeuer A; Schmalreck A; Räder K; Eibel G; Pfaff G
    Arzneimittelforschung; 1989 Jan; 39(1):94-100. PubMed ID: 2785802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An open comparative study of sulbactam/ampicillin vs mezlocillin in adult and pediatric patients. Efficacy and tolerability].
    Chiodo F; Manfredi R; Zucchini A
    Minerva Med; 1991 Jun; 82(6):387-94. PubMed ID: 2067712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [6R-[(R)-2-[3-[2-(p-Aminosulfonyl)anilino-4-hydroxy-5- pyrimidinyl]ureido]-2-(4-hydroxyphenyl)acetamido]-penicillanic acid, sodium salt (VX-VC 43), a new broad-spectrum beta-lactam antibiotic. In vitro and in vivo antibiotic activity].
    Lechner U; Appel KR; Werner RG
    Arzneimittelforschung; 1985; 35(1A):351-5. PubMed ID: 3838677
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.
    Kosmidis J; Doundoulaki P; Stathakis C; Zerefos N; Bounia A; Daikos GK
    Arzneimittelforschung; 1979; 29(12a):1960-2. PubMed ID: 543901
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Bacterial elimination and antibiotic concentration in the gall-bladder during biliary tract infections treated with mezlocillin (author's transl)].
    Helm EB; Wurbs D; Gundlach H; Beyer B; Hagenmüller F; Stille W
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1087-90. PubMed ID: 6455282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Microbiological care of ventilated intensive care patients. Feasibility of diagnosis and therapy of pulmonary infection].
    Füssle R; Biscoping J; Zeiler D; Michaelis G; Sziegoleit A
    Anaesthesist; 1991 Sep; 40(9):491-6. PubMed ID: 1952044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical evaluation of timentin in intensive care].
    Gérard A; Dureux JB; Canton P; May T; Schmit JL
    Pathol Biol (Paris); 1986 May; 34(5):448-50. PubMed ID: 3534719
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Bacteriologic and clinical analysis of nosocomial infections in patients from the intensive care unit].
    Nikodemski T
    Ann Acad Med Stetin; 1999; 45():211-26. PubMed ID: 10909491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mezlocillin in serious surgical infections caused by carbenicillin-resistant bacteria.
    Lewandowski A; Orlowski T; Weuta H
    Infection; 1982; 10 Suppl 3():S125-7. PubMed ID: 6218098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the efficacy and tolerability of mezlocillin in female patients suffering from gynaecological-obstetric infections (author's transl)].
    Weissenbacher ER; Tettenborn D
    Arzneimittelforschung; 1979; 29(12a):1999-2000. PubMed ID: 543911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.